Irving Weissman, who was awarded a grant from the California Institute for Regenerative Medicine through the agency's "tools and technology" grant program to develop ways to generate better-tolerated, transplantable, blood-forming stem cells from induced pluripotent stem cells and to test new ways to prepare recipients for the transplantation of the cells.
Irving Weissman also won this year’s Charles Rodolphe Brupbacher Prize for Cancer Research for his work on healthy and sick stem cells.
Hanna Mikkola, who received the prestigious California Institute for Regenerative Medicine tools and technology award for her work creating a suite of engineered human pluripotent stem cell lines to facilitate the generation of patient specific hematopoietic stem cells.
Congratulations to the following members for the recent publication of their ground-breaking research:
Timm Schroeder, Hartmut Geiger, Michael A. Rieger, Marieke A. G. Essers, David A. Williams, Andreas Trumpp and Michael D. Milsom: Exit from dormancy provokes DNA-damage-induced attrition in haematopoietic stem cells. Nature, 2015; Feb 18. [Epub ahead of print]
Shahin Rafii: Vascular niche promotes hematopoietic multipotent progenitor formation from pluripotent stem cells. J Clin Invest., 2015;125(3):1243–1254.
David G. Kent, Anna L. Godfrey and Anthony R. Green: Effect of Mutation Order on Myeloproliferative Neoplasms. N Engl J Med., 2015; 372:601-612.
John E. Dick: CDK6 Levels Regulate Quiescence Exit in Human Hematopoietic Stem Cells. Cell Stem Cell, 2015 Mar 5;16(3):302-13.
This post has not been tagged.